Comprehensive interpretation of cabergoline's detailed instructions and precautions for use

Cabergoline (Cabergoline) is a dopamine DD₂ receptor agonist, commonly used to treat hyperprolactinemia, pituitary prolactinoma, Parkinson's disease and other diseases. Its mechanism of action is mainly by stimulating dopamine receptors in the hypothalamus-pituitary system, inhibiting the secretion of prolactin (PRL), thereby restoring endocrine balance in the body. Cabergoline is widely used in clinical settings because of its long-lasting effects, relatively mild side effects, and low frequency of medication. The following is a detailed description of the drug and a comprehensive analysis of the precautions for taking it.

1. Basic drug information

Common name: Cabergoline (Cabergoline)

Trade name: Common brands include Dostinex, Cabaser , etc.

Type of drug: Dopamine agonist

Main indications:

1.Treatment of menstrual disorders, infertility or galactorrhea caused by hyperprolactinemia;

2.Treatment of pituitary prolactinoma (including microadenomas and macroadenomas);

3Preventing milk secretion after childbirth (lactation suppression);

4.Adjuvant treatment for Parkinson’s disease (approved in some countries).

Cabergoline is well absorbed in the body, and its plasma concentration reaches its peak in about 2 to 3 hours after oral administration, and its half-life is as long as 60 to 70 hours, so most patients can maintain the efficacy by taking the medicine 1 to 2 times a week. Its metabolism is mainly carried out in the liver and excreted in urine and feces.

2. Instructions for usage and dosage

Cabergoline should be adjusted individually according to the doctor's prescription. The usual dosage is as follows:

1.Treatment of hyperprolactinemia: starting dose is usually 0.25 mg weekly (i.e. 0.25 mg once a week), adjust the dose according to serum prolactin levels, and increase by 0.25 every 1–4 weeks mg, the usual maintenance dose is 0.5–1 mg per week, up to a maximum of 3 mg per week.

2.Prevent postpartum lactation: Take a single dose of 1 mg within 24 hours after delivery, which can effectively inhibit milk secretion.

3.Adjuvant treatment for Parkinson's disease: The initial dose is generally 0.5 mg per day, gradually increasing every week, and the maximum dose can reach 3–5 mg per day.

4. How to take the medicine: The tablet should be taken orally and swallowed whole. It is recommended to take it with or after a meal to reduce gastric irritation and nausea. Due to the long half-life of cabergoline, if the drug is taken weekly, it is recommended to take it at the same time to help maintain stable blood concentration.

3. Common side effects and risk warnings

Cabergoline is generally well tolerated, but it may cause the following side effects:

1.Gastrointestinal reactions: including nausea, vomiting, stomach discomfort, loss of appetite, etc. This is the most common adverse reaction and usually resolves over time. It is recommended to take it with food or reduce the initial dose.

2.Nervous system symptoms: such as dizziness, drowsiness, fatigue or low blood pressure. Some patients may experience orthostatic hypotension when standing up, so they should stand up slowly and avoid sudden changes in posture.

3.Psychiatric symptoms: High-dose or long-term users may experience hallucinations, impulse control disorders (such as compulsive shopping or gambling), etc., especially patients with Parkinson's disease, who should regularly monitor behavioral changes.

4.Cardiovascular reactions: Long-term high-dose use may lead to rare complications such as cardiac valve fibrosis or pleural fibrosis, which are mainly seen in patients undergoing treatment for Parkinson's disease. It is recommended to conduct cardiac ultrasound every 6–12 months. If you have difficulty breathing, edema, or chest pain, you should seek medical attention immediately.

4. Precautions for use and key points for monitoring

1.Regularly monitor prolactin levels: After the start of treatment, detect serum PRL concentration monthly to evaluate efficacy and guide dose adjustment. WhenPRLReturn to normal and maintain it6 for more than 6 months. You can try to stop the drug or reduce the dosage under the guidance of a doctor.

2.Usage during pregnancy and lactation: Women who want to become pregnant should take contraceptive measures while taking the medicine. When planning pregnancy, they should stop taking the medicine 1 months in advance. If you become pregnant unexpectedly during treatment, you should stop taking the medicine in time and consult your doctor. Cabergoline is not recommended during breastfeeding because it inhibits milk production.

3. Patients with abnormal liver and kidney function: Since the drug is mainly metabolized by the liver, patients with liver dysfunction should use it with caution and monitor liver function regularly. People with mild to moderate renal impairment can generally use conventional doses, but require doctor's guidance.

4.Drug interactions: Avoid combined use with dopamine antagonists (such as metoclopramide, chlorpromazine) to avoid weakening the efficacy of the drug; when used simultaneously with antihypertensive drugs, the risk of hypotension may increase; avoid drinking alcohol at the same time.

5. Medication discontinuation and treatment course management

Cabergoline may be discontinued after prolactin levels return to normal and symptoms improve. After stopping the drug, most patients can maintain normal PRL levels, but some people still relapse and need to be re-treated. If long-term maintenance treatment is required, the efficacy and side effects should be regularly evaluated under the guidance of a doctor. For long-term users, cardiac ultrasound and vascular imaging examinations should be performed once a year to prevent the risk of heart valve fibrosis.

Cabergoline is a highly effective and well-tolerated dopamine receptor agonist that can effectively reduce prolactin levels, restore ovulation and improve infertility. It is a first-line drug for the treatment of hyperprolactinemia. The correct way of taking medication (taken after meals, at a fixed time), reasonable dosage adjustment and regular monitoring are the keys to ensuring efficacy and safety. Patients should closely observe body reactions during medication and avoid increasing or decreasing the dose on their own or combining it with other medications. If obvious discomfort occurs, a doctor should be consulted in time to ensure that the treatment is carried out smoothly and safely.

Reference materials:https://www.drugs.com/